Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 8 (4) , 440-447
- https://doi.org/10.1016/s1472-6483(10)60928-5
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The polycystic ovary syndrome: what does insulin resistance have to do with it?Reproductive BioMedicine Online, 2003
- A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive PillsJournal of Clinical Endocrinology & Metabolism, 2003
- Prediction of Insulin Sensitivity in Nonobese Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Troglitazone Improves Ovulation and Hirsutism in the Polycystic Ovary Syndrome: A Multicenter, Double Blind, Placebo-Controlled TrialJournal of Clinical Endocrinology & Metabolism, 2001
- Lactic Acidosis Rates in Type 2 DiabetesDiabetes Care, 1998
- Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulationJournal of Clinical Endocrinology & Metabolism, 1993
- Impact of Obesity on Insulin Action in Volunteers with Normal Glucose Tolerance: Demonstration of a Threshold for the Adverse Effect of Obesity*Journal of Clinical Endocrinology & Metabolism, 1990
- IDENTIFICATION OF PLACENTAL PROTEIN 14 AS AN IMMUNOSUPPRESSIVE FACTOR IN HUMAN REPRODUCTIONThe Lancet, 1987
- Insulin Enhancement of Luteinizing Hormone and Follicle-Stimulating Hormone Release by Cultured Pituitary Cells*Endocrinology, 1981